208 related articles for article (PubMed ID: 31895187)
1. Cannabinoids as an Emerging Therapy for Posttraumatic Stress Disorder and Substance Use Disorders.
Cohen J; Wei Z; Phang J; Laprairie RB; Zhang Y
J Clin Neurophysiol; 2020 Jan; 37(1):28-34. PubMed ID: 31895187
[TBL] [Abstract][Full Text] [Related]
2. Marijuana and other cannabinoids as a treatment for posttraumatic stress disorder: A literature review.
Steenkamp MM; Blessing EM; Galatzer-Levy IR; Hollahan LC; Anderson WT
Depress Anxiety; 2017 Mar; 34(3):207-216. PubMed ID: 28245077
[TBL] [Abstract][Full Text] [Related]
3. Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review.
Orsolini L; Chiappini S; Volpe U; Berardis D; Latini R; Papanti GD; Corkery AJM
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31450833
[TBL] [Abstract][Full Text] [Related]
4. Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder.
Hill MN; Campolongo P; Yehuda R; Patel S
Neuropsychopharmacology; 2018 Jan; 43(1):80-102. PubMed ID: 28745306
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and Complex Posttraumatic Stress Disorder: A Narrative Review With Considerations of Benefits and Harms.
Dagan Y; Yager J
J Nerv Ment Dis; 2020 Aug; 208(8):619-627. PubMed ID: 32433200
[TBL] [Abstract][Full Text] [Related]
6. Use and effects of cannabinoids in military veterans with posttraumatic stress disorder.
Betthauser K; Pilz J; Vollmer LE
Am J Health Syst Pharm; 2015 Aug; 72(15):1279-84. PubMed ID: 26195653
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention.
Mizrachi Zer-Aviv T; Segev A; Akirav I
Behav Pharmacol; 2016 Oct; 27(7):561-9. PubMed ID: 27551883
[TBL] [Abstract][Full Text] [Related]
8. Positive posttraumatic stress disorder screens among first-time medical cannabis patients: prevalence and association with other substance use.
Bohnert KM; Perron BE; Ashrafioun L; Kleinberg F; Jannausch M; Ilgen MA
Addict Behav; 2014 Oct; 39(10):1414-7. PubMed ID: 24930048
[TBL] [Abstract][Full Text] [Related]
9. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program.
Greer GR; Grob CS; Halberstadt AL
J Psychoactive Drugs; 2014; 46(1):73-7. PubMed ID: 24830188
[TBL] [Abstract][Full Text] [Related]
10. Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment.
Krumm BA
Nurse Pract; 2016 Jan; 41(1):50-4. PubMed ID: 26678423
[TBL] [Abstract][Full Text] [Related]
11. Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans.
Wolfgang AS; Hoge CW
JAMA Psychiatry; 2023 Sep; 80(9):869-870. PubMed ID: 37436761
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment.
Davis AK; Bonar EE; Ilgen MA; Walton MA; Perron BE; Chermack ST
Addict Behav; 2016 Dec; 63():132-6. PubMed ID: 27475408
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid interventions for PTSD: Where to next?
Ney LJ; Matthews A; Bruno R; Felmingham KL
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():124-140. PubMed ID: 30946942
[TBL] [Abstract][Full Text] [Related]
14. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Hindocha C; Cousijn J; Rall M; Bloomfield MAP
J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
[No Abstract] [Full Text] [Related]
15. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
Botsford SL; Yang S; George TP
Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
[TBL] [Abstract][Full Text] [Related]
16. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
Forsythe ML; Boileau AJ
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
[TBL] [Abstract][Full Text] [Related]
17. Using cannabis to help you sleep: heightened frequency of medical cannabis use among those with PTSD.
Bonn-Miller MO; Babson KA; Vandrey R
Drug Alcohol Depend; 2014 Mar; 136():162-5. PubMed ID: 24412475
[TBL] [Abstract][Full Text] [Related]
18. Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.
Fattore L; Piva A; Zanda MT; Fumagalli G; Chiamulera C
Psychopharmacology (Berl); 2018 Feb; 235(2):433-445. PubMed ID: 29178010
[TBL] [Abstract][Full Text] [Related]
19. Benefits and Harms of Plant-Based Cannabis for Posttraumatic Stress Disorder: A Systematic Review.
O'Neil ME; Nugent SM; Morasco BJ; Freeman M; Low A; Kondo K; Zakher B; Elven C; Motu'apuaka M; Paynter R; Kansagara D
Ann Intern Med; 2017 Sep; 167(5):332-340. PubMed ID: 28806794
[TBL] [Abstract][Full Text] [Related]
20. Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study.
De Aquino JP; Sofuoglu M; Stefanovics EA; Rosenheck RA
Am J Drug Alcohol Abuse; 2020 Nov; 46(6):812-822. PubMed ID: 33035104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
